Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for Visuospatial Cognitive Decline in Parkinson Disease
NCT04497168Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Apr 2021
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of citalopram in Parkinson's disease (PD), sponsored by University of Michigan. Started Apr 2021; status: completed.
02
Drugs
citalopram
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04497168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04497168.